Sophie is a Chartered UK and European Patent Attorney specialising in biotechnology, with particular expertise in the healthcare sector. Since joining Marks & Clerk in 2011, she has built a practice focussed on cutting-edge innovations in diagnostics and therapeutics in a range of medical fields such as neurodegenerative diseases and oncology, including immune-oncology. Sophie's technical experience spans a broad range of life sciences innovations, including PCR-based diagnostics, biomarkers, diagnostic devices (such as lateral flow tests and ELISA-based systems), peptide vaccines, oncolytic viruses, combination therapies, therapeutic cannabinoids and antibodies. Her work also extends to cell cultures, enzymes, food technology, gene-based inventions and medical devices.

Working with clients ranging from start-ups and university tech transfer offices to SMEs and multinational corporations, Sophie has developed long-standing relationships built on strategic advice and commercial insight. She has worked with one serial entrepreneur for over a decade and takes particular pride in the strong feedback she receives from early-stage and smaller companies navigating their first patent journeys.

Sophie manages international patent portfolios across Europe, the UK, the US, China, Japan and beyond. Her full-service approach to IP covers drafting and prosecution, freedom-to-operate and novelty searches, infringement opinions, oppositions and appeals. She has also successfully guided patent applications from initial drafting through to grant and opposition defence at the European Patent Office.

Sophie graduated from Cambridge University with a degree in Biological Natural Sciences and completed her patent attorney training at Marks & Clerk. She is bilingual in English and French and has a working knowledge of Spanish.